As the market seems to be in comeback mode, it helps to be aware that the best (and probably biggest) wealth creator of the last couple of ...

There are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...

Chemicals meant to protect the planet are now causing a new issue. Replacements for ozone-damaging CFCs are forming a stubborn chemical, TF...

Bats possess a unique, preactivated innate immune defense that stops viruses from fully replicating, even after cell entry. This remarkable...

In a pivotal discussion at the G7 summit, France is highlighting urgent concerns about the global economic landscape. China's robust export...

The Indian stock market is no longer correcting only because of sentiment. It is now adjusting to the possibility of weaker numbers in the ...

Cipla is charting its next growth phase with a strong focus on innovation, complex generics, and biosimilars. The company plans significant...

As Cipla approaches its centenary, the company is redefining its strategy by prioritizing innovation to amplify revenues. With ambitions to...

Private equity funds are pouring hundreds of millions of dollars into Kerala’s healthcare sector, reshaping a system long dominated by inde...

Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...

Rudy Giuliani remains in critical but stable condition at a Florida hospital as of Sunday evening, May 3, 2026. No cause for the hospitaliz...

India’s demographic advantage—with over 65% of its population under 35—faces growing pressure due to weak job creation, skill gaps and risi...

Metal stocks are outperforming defensive sectors, delivering strong returns driven by structural demand shifts and supply constraints. Fact...

DR Sudhir Kumar, a Hyderabad-based neurologist at Apollo Hospitals, revealed a case in which a woman experienced strange pain in her legs f...

Health insurance premiums in India are rising by up to 25% due to escalating healthcare costs, increased claims, and changing risk profiles...

The report challenges the perception of CFS as a rare illness, emphasising its impact on a broader population.

The criteria to objectively define long-COVID is still evolving, but WHO recently described it as a post-COVID-19 condition in individuals ...